ATE145429T1 - Makrocyclische lactone und ein stamm zu seiner herstellung - Google Patents
Makrocyclische lactone und ein stamm zu seiner herstellungInfo
- Publication number
- ATE145429T1 ATE145429T1 AT93905810T AT93905810T ATE145429T1 AT E145429 T1 ATE145429 T1 AT E145429T1 AT 93905810 T AT93905810 T AT 93905810T AT 93905810 T AT93905810 T AT 93905810T AT E145429 T1 ATE145429 T1 AT E145429T1
- Authority
- AT
- Austria
- Prior art keywords
- macrocyclic lactones
- hydroxy
- hydrogen
- methoxy
- ferm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
- C12R2001/55—Streptomyces hygroscopicus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2966992 | 1992-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE145429T1 true ATE145429T1 (de) | 1996-12-15 |
Family
ID=12282523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93905810T ATE145429T1 (de) | 1992-02-17 | 1993-02-11 | Makrocyclische lactone und ein stamm zu seiner herstellung |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0627009B1 (de) |
| JP (1) | JP3140228B2 (de) |
| AT (1) | ATE145429T1 (de) |
| AU (1) | AU3658693A (de) |
| CA (1) | CA2128529A1 (de) |
| DE (1) | DE69306102T2 (de) |
| DK (1) | DK0627009T3 (de) |
| ES (1) | ES2095044T3 (de) |
| FI (1) | FI943773A0 (de) |
| GR (1) | GR3022309T3 (de) |
| IL (1) | IL104652A0 (de) |
| MX (1) | MX9300804A (de) |
| WO (1) | WO1993016189A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT98990A (pt) * | 1990-09-19 | 1992-08-31 | American Home Prod | Processo para a preparacao de esteres de acidos carboxilicos de rapamicina |
| GB9103430D0 (en) | 1991-02-19 | 1991-04-03 | Smithkline Beecham Plc | Novel compound |
| ZA935110B (en) * | 1992-07-17 | 1994-02-04 | Smithkline Beecham Corp | Rapamycin derivatives |
| ZA935111B (en) * | 1992-07-17 | 1994-02-04 | Smithkline Beecham Corp | Rapamycin derivatives |
| ZA935112B (en) * | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
| GB9302569D0 (en) * | 1993-02-10 | 1993-03-24 | Smithkline Beecham Plc | Novel compound |
| USRE37421E1 (en) | 1993-07-16 | 2001-10-23 | Smithkline Beecham Corporation | Rapamycin derivatives |
| US5527907A (en) * | 1993-11-19 | 1996-06-18 | Abbott Laboratories | Macrolide immunomodulators |
| EP0729471A1 (de) * | 1993-11-19 | 1996-09-04 | Abbott Laboratories | Semisynthetische rapamycin analoge mit immunomodulatorischer wirkung |
| WO1996006847A1 (en) * | 1994-08-31 | 1996-03-07 | Pfizer Inc. | Process for preparing demethylrapamycins |
| WO2001034816A1 (en) * | 1999-10-29 | 2001-05-17 | Kosan Biosciences, Inc. | Rapamycin analogs |
| CN1551767A (zh) * | 2001-02-19 | 2004-12-01 | ��˹��ŵ�� | 癌症的治疗 |
| KR100431573B1 (ko) * | 2002-03-12 | 2004-05-17 | 한국해양연구원 | 방선균 유래의 신규 생리 활성 물질, 이의 추출 방법 및이를 포함하는 약학적 조성물 |
| ES2544624T3 (es) * | 2002-07-16 | 2015-09-02 | Buck Institute For Research On Aging | Producción de policétidos |
| WO2004101803A2 (en) | 2003-05-12 | 2004-11-25 | Wyeth Holdings Corporation | Process for producing anticancer agent ll-d45042 |
| GB0504995D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Use of a compound |
| GB0504994D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
| US10695327B2 (en) | 2006-09-13 | 2020-06-30 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
| US7867988B2 (en) * | 2006-09-13 | 2011-01-11 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
| US8088789B2 (en) | 2006-09-13 | 2012-01-03 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
| EP2704709B1 (de) | 2011-05-02 | 2020-09-02 | Altaba, Ariel Ruiz | Macrocyclische lactone und ihre verwendung |
| WO2016139331A1 (en) | 2015-03-05 | 2016-09-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of melanoma |
| WO2017144546A1 (en) | 2016-02-23 | 2017-08-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of nasopharyngeal carcinoma |
| WO2020212484A1 (en) | 2019-04-17 | 2020-10-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of nlrp3 inflammasome mediated il-1beta dependent disorders |
| KR102199005B1 (ko) * | 2019-12-13 | 2021-01-06 | 전남대학교산학협력단 | 휴미콜라 속 js-0112 균주 및 이를 함유하는 항진균제 조성물 |
| WO2021198511A1 (en) | 2020-04-03 | 2021-10-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of sars-cov-2 infection |
| WO2022008597A1 (en) | 2020-07-08 | 2022-01-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical composition for the treatment of infectious diseases |
| WO2024261302A1 (en) | 2023-06-22 | 2024-12-26 | Institut National de la Santé et de la Recherche Médicale | Nlrp3 inhibitors, pak1/2 inhibitors and/or caspase 1 inhibitors for use in the treatment of rac2 monogenic disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4543334A (en) | 1983-12-16 | 1985-09-24 | Pfizer Inc. | Streptomyces capable of producing neutral macrolide antibacterial agents |
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| GB9103430D0 (en) * | 1991-02-19 | 1991-04-03 | Smithkline Beecham Plc | Novel compound |
| US5091389A (en) * | 1991-04-23 | 1992-02-25 | Merck & Co., Inc. | Lipophilic macrolide useful as an immunosuppressant |
-
1992
- 1992-12-02 JP JP04323407A patent/JP3140228B2/ja not_active Expired - Fee Related
-
1993
- 1993-02-08 IL IL104652A patent/IL104652A0/xx unknown
- 1993-02-11 AT AT93905810T patent/ATE145429T1/de not_active IP Right Cessation
- 1993-02-11 EP EP93905810A patent/EP0627009B1/de not_active Expired - Lifetime
- 1993-02-11 AU AU36586/93A patent/AU3658693A/en not_active Abandoned
- 1993-02-11 FI FI943773A patent/FI943773A0/fi unknown
- 1993-02-11 DK DK93905810.3T patent/DK0627009T3/da active
- 1993-02-11 DE DE69306102T patent/DE69306102T2/de not_active Expired - Fee Related
- 1993-02-11 WO PCT/US1993/001087 patent/WO1993016189A1/en not_active Ceased
- 1993-02-11 ES ES93905810T patent/ES2095044T3/es not_active Expired - Lifetime
- 1993-02-11 CA CA002128529A patent/CA2128529A1/en not_active Abandoned
- 1993-02-15 MX MX9300804A patent/MX9300804A/es unknown
-
1997
- 1997-01-16 GR GR970400070T patent/GR3022309T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI943773A7 (fi) | 1994-08-16 |
| DK0627009T3 (da) | 1997-05-05 |
| AU3658693A (en) | 1993-09-03 |
| MX9300804A (es) | 1994-07-29 |
| FI943773A0 (fi) | 1994-08-16 |
| DE69306102D1 (de) | 1997-01-02 |
| EP0627009A1 (de) | 1994-12-07 |
| DE69306102T2 (de) | 1997-03-13 |
| JPH05292948A (ja) | 1993-11-09 |
| GR3022309T3 (en) | 1997-04-30 |
| IL104652A0 (en) | 1993-06-10 |
| WO1993016189A1 (en) | 1993-08-19 |
| EP0627009B1 (de) | 1996-11-20 |
| ES2095044T3 (es) | 1997-02-01 |
| CA2128529A1 (en) | 1993-08-19 |
| JP3140228B2 (ja) | 2001-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69306102D1 (de) | Makrocyclische lactone und ein stamm zu seiner herstellung | |
| SG163194G (en) | BMY-41950 antitumor antibiotic | |
| DE3378059D1 (en) | Antitumor antibiotics | |
| AU1181292A (en) | Process for producing cyclosporin a and/or c | |
| WO2001074850A1 (en) | Antibiotics tripropeptins and process for producing the same | |
| KR100360568B1 (en) | 16-membered ring macrolide derivative and method for manufacturing the same | |
| EP0491956A4 (en) | Reveromycin a, production thereof, and antitumor drug and fungicide | |
| AU547035B2 (en) | 19-epi-dianemycin | |
| EP0682038A4 (de) | 5-0-desosaminylerythronolid-derivat. | |
| ATE70262T1 (de) | Azoxyverbindungen und verfahren zu ihrer herstellung. | |
| DK0638125T3 (da) | Actinoplaner til produktion af rapamycin | |
| ATE111092T1 (de) | Antibiotikum a80915 und verfahren zu seiner herstellung. | |
| CA2041237A1 (en) | UCF1 Compounds Derivatives Thereof and Processes for Their Preparation | |
| CA2158482A1 (en) | UCF1 Compounds, Derivatives Thereof and Processes for Their Preparation | |
| ATE158293T1 (de) | Polycyclische 31668p- und 31668u-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antibiotische oder antitumorale arzneistoffe | |
| ATE149174T1 (de) | Antibiotikum ll-e19020 epsilon und ll-e19029 epsilon 1 | |
| MX9701853A (es) | Antibiotico especifico de legionella, micro-organismo que produce el antibiotico y proceso para producir el mismo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |